UPDATE: Cellect Biotechnology Q3 EPS $(0.12) Up From $(0.29) YoY

Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.12) per share. This is a 58.62 percent increase over losses of $(0.29) per share from the same period last year.

Benzinga · 11/19/2019 12:08

Cellect Biotechnology (NASDAQ:APOP) reported quarterly losses of $(0.12) per share. This is a 58.62 percent increase over losses of $(0.29) per share from the same period last year.